International Pulmonologist Consensus on COVID 19 03 Apr 2020 The novel coronavirus disease (COVID-19) has been spreading at a rapid rate across the world, which made the World Health Organization (WHO) to declare it as pandemic disease. A lot is still unknown about this virus.   Because of this Pulmonologist’s from different nations, affected by … Continue reading International Pulmonologist Consensus on COVID 19

ICRIER’s HPI stakeholder Seminar was organized to mark the culmination and release of Health Policy Initiative – research reports and policy briefs on “International cooperation for registration of medicines: Opportunities for India” and “Challenges and prospects for clinical trials in India: A regulatory perspective”.   The Inaugural address of the workshop was delivered by Shri … Continue reading ICRIER’s Stakeholder Seminar on Pharmaceuticals in India – The next leap – 28th April 2017

AMNET collaboration – Latin America

Under its research program on ‘Drug Regulatory reforms in India’, ICRIER’s Health Policy Initiative organized a consultative workshop on May 1, 2015 at India Habitat Centre, New Delhi, to discuss the first drafts of the two papers under the project viz. Administrative Structure and Functions of Drug Regulatory Authorities in India, and Drug Quality and … Continue reading Consultative Workshop on Drug Regulatory Reforms in India – 1st May, 2015

A multi-phased Health Policy initiative was launched at ICRIER to develop actionable policy recommendations for health sector reforms in India. ICRIER has started out with two scoping workshops – on drug regulation and chronic care – to identify problem areas. The workshop on Drug Regulatory Reforms in India was organised on March 31, 2014 in … Continue reading Scoping Workshop on Drug Regulatory Reforms in India – 31st March, 2014